Editor's Note
The Department of Health and Human Services (HHS) announced on December 11 that it would purchase 100 million additional doses of Moderna’s COVID-19 vaccine.
The vaccine, which was developed by Moderna with scientists from the National Institute of Allergy and Infectious Diseases (NIAID), is scheduled for a December 17 review by the Food and Drug Administration. Anthony Fauci, MD, is director of NIAID.
The purchase doubles the amount of Moderna vaccine owned by the federal government to 200 million.
Read More >>Takeaways • Determining the return on investment (ROI) for a…
Artificial intelligence (AI) has made inroads into nearly every area…
It is with great excitement that we welcome you to…
Free Daily News